FCP
HCA icon

Fidelis Capital Partners’s HCA Healthcare HCA Stock Holding History

Fidelis Capital Partners’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$841K Sell
2,156
-15
-0.7% -$6.34K 0.05% 255
2026
Q1 		$1.03M Sell
2,171
-10
-0.5% -$5.03K 0.07% 206
2025
Q4 		$1.02M Sell
2,181
-13
-0.6% -$6.04K 0.07% 199
2025
Q3 		$935K Buy
2,194
+11
+0.5% +$4.26K 0.07% 204
2025
Q2 		$799K Buy
2,183
+10
+0.5% +$3.6K 0.07% 201
2025
Q1 		$713K Buy
2,173
+16
+0.7% +$5.15K 0.08% 199
2024
Q4 		$721K Sell
2,157
-12
-0.6% -$4.19K 0.07% 202
2024
Q3 		$889K Sell
2,169
-1
-0% -$366 0.11% 164
2024
Q2 		$764K Buy
2,170
+99
+5% +$32.2K 0.11% 160
2024
Q1 		$691K Sell
2,071
-315
-13% -$96.3K 0.1% 176
2023
Q4 		$646K Buy
2,386
+383
+19% +$94.7K 0.14% 146
2023
Q3 		$493K Buy
2,003
+299
+18% +$81.8K 0.17% 132
2023
Q2 		$517K Buy
1,704
+137
+9% +$38.1K 0.19% 129
2023
Q1 		$436K Buy
1,567
+531
+51% +$135K 0.19% 131
2022
Q4 		$259K Buy
+1,036
New +$232K 0.31% 93

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelis Capital Partners's HCA Position: Q2 2026 in Review

Fidelis Capital Partners reduced its HCA Healthcare (HCA) stake by 0.69% in Q2 2026, selling an estimated $6.34K and leaving 2,156 shares worth $841K. The position accounts for 0.05% of the portfolio, ranked #255.

Fidelis Capital Partners first reported a position in HCA in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.03M in Q1 2026. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Fidelis Capital Partners held 2,156 shares of HCA Healthcare worth $841K as of Q2 2026.
  • Fidelis Capital Partners sold 15 HCA Healthcare shares in Q2 2026, an estimated $6.34K.
  • HCA Healthcare made up 0.05% of Fidelis Capital Partners's portfolio in Q2 2026, its #255 holding.
  • Fidelis Capital Partners first reported a position in HCA Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Fidelis Capital Partners's HCA Healthcare position peaked at $1.03M in Q1 2026.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.